Caremax Inc's Competitiveness
A competitive positioning analysis and financial ratio benchmarking of Caremax Inc (CMAX) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.
Key Findings: Caremax Inc vs Its Competitors
- TTM: Trailing 12-month revenue of 552M vs 423,105M combined for its competitors (0.1% combined share).
- Trending: Latest-quarter revenue run-rate is accelerating (+44.0% annualized vs trailing 12 months), vs decelerating (-13.1%) for its tracked peer group.
- Growth: Caremax Inc generated -11.5% revenue growth year over year in Q2 2024, vs 2.6% for its competitors combined.
- Profitability: Its -85.9% net margin compares with 1.0% for the peer group.
- Peer revenue share: Caremax Inc accounted for 0.2% of combined revenue among its tracked peer group, down from 0.3% a year earlier.
- Peer differentiation: Revenue per employee of $0.55M compares with $1.35M for the peer group (0.4x).
Every figure above is sourced and cited in detail further down this page (Market Structure, Profitability & Cost Structure, Productivity vs Peers).
CMAX Sales vs. its Competitors, Q2 2024
Caremax Inc reported revenue contraction of 11.50 % year on year in Q2 2024, below its competitors' combined revenue growth of 2.57 %.
With a net margin of -85.87 %, Caremax Inc reported lower profitability than its competitors (1.00 %).
Caremax Inc generated 0.22 % of the combined sales of its peer group, down from 0.25 % a year earlier.
API endpoints for this dataset
Caremax Inc vs. its Competitors, Q2 2024
Revenue growth, year on year
Net margin
Revenue run-rate vs trailing 12 months
TTM net margin
TTM = trailing twelve months. Run-rate annualizes the latest quarter (×4) and compares it to TTM. In millions of $. High-Confidence Competitors are named as a competitor directly in Caremax Inc reports; Similar-Size Competitors are the closest peers by market-cap rank within the same industry; Similar Growth & Profitability Competitors are the closest peers by combined revenue growth, operating margin and ROIC, all independent of the competitor list.
TTM revenue, latest-quarter run-rate and net income/margin benchmarked across Caremax Inc and its 4 competitor groupings. Available under Commercial License.
| Entity | TTM Revenue | Rev Run-rate vs TTM |
|---|---|---|
| Caremax Inc | $12,345M | +12.3% · Accelerating |
| Competitors combined | $12,345M | +12.3% · Accelerating |
| High-Confidence Competitors (3) | $12,345M | +12.3% · Accelerating |
TTM revenue, run-rate and net margin benchmarking across Caremax Inc's competitor groups requires a Commercial License.
For context: the Healthcare Facilities industry grew revenue 14.7% year over year, combined, vs -11.5% for Caremax Inc. Caremax Inc's share of combined industry revenue moved from 0.22% to 0.17%, a loss of 0.05 percentage points.
Caremax Inc's Competitor Quality Breadth
Group definitions: see Methodology: Performance Group Definitions.
| Entity | Profitable | Expanding | Above Industry Growth | Distressed |
|---|---|---|---|---|
| Caremax Inc | - | No | No | Yes |
| Competitors combined (6) | ||||
| High-Confidence Competitors (6) |
Source: CSIMarket API, trailing 12 months. Altman Z-Score is not shown here: it is not populated in the underlying data for any company. Percentages are of companies in each group that report the relevant metric, not of the full group size.
CMAX Stock Performance relative to its Competitors
CMAX Stock Performance relative to High-Confidence Competitors
5 Best-Performing Tracked Competitors, Trailing 12 Months
| # | Competitor | TTM Share Price Return | vs U.S.A. 500 |
|---|---|---|---|
| 1 | Marpai Inc | 282.9% | Outperformed |
| 2 | Teladoc Health Inc | 282.9% | Outperformed |
| 3 | Cvs Health Corporation | 282.9% | Outperformed |
TTM share price return and U.S.A. 500 outperformance for Caremax Inc's best-performing competitors requires a Commercial License.
Source: CSIMarket API, trailing 12 months.
Caremax Inc's Comment on Competition and Industry Peers
Publicly Traded Peers of Caremax Inc
Revenue and income for trailing 12 months, in millions of $, except employees| Company | Market Cap | Revenues |
|---|---|---|
 Caremax Inc |
2.18 | 551.77 |
 Cvs Health Corporation |
114,911.91 | 420,614.00 |
 Oak Street Health Inc |
9,285.65 | 2,399.10 |
 Teladoc Health Inc |
1,625.97 | 2,468.14 |
 Marpai Inc |
64.65 | 16.63 |
 Pacific Health Care Organization Inc |
13.46 | 6.37 |
| SUBTOTAL | 125,915.88 | 429,011.29 |
Sign in to see all competitors of Caremax Inc .
Sources: see Methodology: Peer & Competitor Identification, Sourcing.
Updated on:
Focus of this report: publicly traded companies. Ten additional tables on Caremax Inc versus competitors, including market share analysis, are in the navigation menu under Competition. To download the tables, please subscribe.
Caremax Inc's Competitors Named by the Company
Competitive relationships identified from Caremax Inc reports and corroborating sources, each with a basis and confidence.| Competitor | Basis | Confidence |
|---|---|---|
| Oak Street Health | Company report | 85% |
| Amazon | Company report | 85% |
| Aetna | Company report | 85% |
| CVS Health | Company report | 85% |
| One Medical | Company report | 85% |
| Leon Medical Centers | Company report | 85% |
| agilon health | Company report | 85% |
| Cano Health | Company report | 85% |
| ChenMed | Company report | 85% |
| Deerfield Management | Company report | 85% |
| Deerfield Funds | Company report | 85% |
| 1life Healthcare Inc | Company report | 85% |
| Teladoc Health Inc | Company report | 85% |
Company report basis, confidence, active dates and source counts for Caremax Inc's named competitors require a Commercial License.
Methodology: see Methodology: Peer & Competitor Identification, Sourcing.
Caremax Inc's Business Segment Mix vs Peers
Revenue by operating segment or division, as named and reported by each company. Segment names are the filer's own and are not standardized across companies. Do not assume a same-named or similarly-named segment is defined identically between two companies. Shares are of each company's own total revenue and are not required to sum to 100% (intersegment revenue, unallocated items).| Company | Largest Segment |
|---|---|
| Cvs Health Corporation | Health Services 48.03 % |
| Teladoc Health Inc | Teladoc Health Integrated Care 65.85 % |
Source: operating segment revenue as reported in each company's reports (10-K/10-Q), via the CSIMarket API, leaf-level reportable segments only (parent roll-up segments are excluded where sub-segments are separately disclosed).
Caremax Inc's Productivity vs Peers Comparison
Revenue and income per employee, trailing 12 months, in $; market cap in millions of $| Company | Market Cap | Revenue / Employee | Income / Employee |
|---|---|---|---|
| Caremax Inc | 2 | 551,766 | -782,856 |
| Cvs Health Corporation | 114,912 | 1,402,047 | 36,823 |
| Oak Street Health Inc | 9,286 | 299,888 | -57,150 |
| Teladoc Health Inc | 1,626 | 440,740 | -27,647 |
| Marpai Inc | 65 | 155,467 | -157,813 |
| Pacific Health Care Organization Inc | 13 | 205,413 | 35,172 |
| PEERS TOTAL | 125,914 | 1,354,008 | 28,134 |
Caremax Inc's Geographic Revenue Exposure vs Peers
Revenue by country/region as reported in each company's most recent report. Disclosure granularity varies by filer (some report by country, others by broad region) and is shown as disclosed.| Company | Largest Market |
|---|---|
| Teladoc Health Inc | United States 80.85 % |
Source: revenue geography as reported in each company's reports (10-K/10-Q), via the CSIMarket API. Percentages are of that company's own total consolidated revenue for its most recent reported period.
Caremax Inc's Profitability & Cost Structure
Trailing 12-month margins from SEC-filed financials. Operating margin is compared to the Healthcare Facilities industry median; gross margin, EBITDA margin and capital intensity are compared to the live industry average (113 companies). See the full Healthcare Facilities industry profitability benchmarks.| Metric | Company | Industry | Difference |
|---|---|---|---|
| Gross Margin | 76.78 % | 34.25 % (avg) | +42.5 pp |
| Operating Margin | - | industry median | - |
| EBITDA Margin | - | 3.04 % (avg) | - |
| Capital Intensity (Capex / Revenue) | 1.84 % | 3.79 % (avg) | -2.0 pp |
Source: CSIMarket API, trailing 12 months. SG&A and R&D as a share of revenue have limited coverage as this data is backfilled and appear only where reported. Higher capital intensity is not inherently negative; it reflects the industry's asset requirements.
Caremax Inc's Multi-Year Financial Trajectory
Fiscal-year revenue growth, operating margin, return on invested capital and P/E, as reported in company reports.| Metric | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| Revenue Growth | - | - | 113.39 % | 19.01 % |
| Operating Margin | - | -8.59 % | -17.77 % | -87.36 % |
| Return on Invested Capital | - | -2.17 % | - | - |
| P/E | - | 1,189.2x | 51.5x | - |
Source: CSIMarket API, fiscal-year figures. P/E is this company's own historical ratio at each fiscal year end and can swing sharply around an earnings trough: that is real, not a data error.
Caremax Inc's Competitive Forces (Porter's Five Forces)
Only the forces this data can support honestly are shown; the other three are marked as such rather than guessed.| Force | Assessment | Basis |
|---|---|---|
| Barriers to Entry | Lower than typical for the industry | Capital intensity (capex / revenue) of 1.84 % vs industry average 3.79 % (see Profitability & Cost Structure above) |
Note: see Methodology: Porter's Five Forces. Supplier power and buyer power are covered on Caremax Inc's dedicated Suppliers and Customers pages, not here.
Caremax Inc's SWOT
Every point below is a fixed rule applied to a metric already shown elsewhere on this page (Market Structure, Profitability, Valuation, Run-Rate, Stock Performance, Quality Breadth) not an independent strategic assessment. A blank quadrant means no rule was met, not that none apply.Strengths
- Latest-quarter revenue run-rate is accelerating (+44.0% annualized vs trailing 12 months).
Weaknesses
- Piotroski F-Score of 2 or below, the standard financial-distress signal.
Opportunities
- A meaningful share of competitors (33.30 %) show financial-distress signals, a possible opening to gain share.
Threats
- Tracked peer group's revenue run-rate is broadly decelerating (-13.1% annualized).
Methodology: see Methodology: SWOT Analysis.
Caremax Inc's Financial Strength vs Peers Comparison
Quick ratio, working capital, debt to equity and asset turnover, trailing 12 months| Company | Quick Ratio | Working Capital | Debt / Equity |
|---|---|---|---|
| Caremax Inc | 0.10 | 0.41 | 0.73 |
| Cvs Health Corporation | 0.12 | 0.86 | 0.80 |
| Oak Street Health Inc | 0.15 | 1.46 | - |
| Teladoc Health Inc | 0.88 | 1.28 | 0.75 |
| Marpai Inc | 0.01 | 0.42 | - |
| Pacific Health Care Organization Inc | 21.69 | 30.15 | - |
Quick ratio = cash / current liabilities; working capital ratio = current assets / current liabilities; asset turnover = revenue / total assets. Peers in the Blank Checks industry are excluded.
Caremax Inc's Revenue and Income Growth vs Peers
Quarterly revenue and net income growth, year over year and quarter over quarter| Company | Period | Revenue Y/Y | Income Y/Y |
|---|---|---|---|
| Caremax Inc | Q2 2024 | -11.5 % | - |
| Cvs Health Corporation | Q3 2026 | +5.4 % | - |
| Oak Street Health Inc | Q1 2023 | +46.4 % | - |
| Teladoc Health Inc | Q3 2026 | -3.4 % | - |
| Marpai Inc | Q2 2026 | -10.5 % | - |
| Pacific Health Care Organization Inc | Q3 2026 | -4.7 % | +50.0 % |
| PEERS TOTAL | +5.3 % | - |
Growth is shown only where both periods are positive. Peers in the Blank Checks industry are excluded.
Caremax Inc's Peers' Costs of Sales and Capital Expenditures
Context for revenue growth: peer costs and capex, year over year and quarter over quarter| Company | Period | Costs Y/Y | Capex Y/Y |
|---|---|---|---|
| Caremax Inc | Q2 2024 | +6.0 % | -77.3 % |
| Cvs Health Corporation | Q3 2026 | +7.3 % | +17.0 % |
| Oak Street Health Inc | Q1 2023 | -72.8 % | -14.1 % |
| Teladoc Health Inc | Q3 2026 | +1.6 % | -2.5 % |
| Marpai Inc | Q2 2026 | -19.0 % | - |
| Pacific Health Care Organization Inc | Q3 2026 | - | -11.9 % |
Caremax Inc's Returns and Turnover vs Peers
ROA, ROI and ROE (trailing 12 months), receivables and inventory turnover| Company | ROA | ROI | ROE |
|---|---|---|---|
| Caremax Inc | - | - | - |
| Cvs Health Corporation | 4.34% | 6.34% | 14.09% |
| Oak Street Health Inc | - | - | - |
| Teladoc Health Inc | - | - | - |
| Marpai Inc | - | - | - |
| Pacific Health Care Organization Inc | 7.83% | 8.09% | 8.10% |
ROA = net income / total assets; ROI = net income / investments; ROE = net income / equity; turnover ratios use trailing 12 month revenue (receivables) and cost of sales (inventory).
Caremax Inc's Valuation vs Peers
P/E, price to sales, PEG, price to cash flow and price to book| Company | P/E | Price / Sales |
|---|---|---|
| Caremax Inc | - | 0.00 |
| Cvs Health Corporation | 10.34 | 0.27 |
| Oak Street Health Inc | - | 3.87 |
| Teladoc Health Inc | - | 0.66 |
| Marpai Inc | - | 3.89 |
| Pacific Health Care Organization Inc | 10.50 | 2.11 |
| PEERS AVERAGE | 15.51 | 0.29 |
P/E = price / diluted EPS (trailing 12 months); PEG = P/E divided by EPS growth; the average row divides the peers' combined market cap by their combined income, sales, cash flow and equity.